Cargando…
Analysis of Immune Gene Expression Subtypes Reveals Osteosarcoma Immune Heterogeneity
BACKGROUND: Osteosarcoma (OS) patients have a poor response to immunotherapy due to the sheer complexity of the immune system and the nuances of the tumor-immune microenvironment. Methodology. To gain insights into the immune heterogeneity of OS, we identified robust clusters of patients based on th...
Autores principales: | Wan, Ben, Wang, Renxian, Nie, Jingjun, Sun, Yuyang, Zhang, Bowen, Liu, Weifeng, Chen, Dafu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7939746/ https://www.ncbi.nlm.nih.gov/pubmed/33727926 http://dx.doi.org/10.1155/2021/6649412 |
Ejemplares similares
-
Carboxypeptidase E is a prognostic biomarker co-expressed with osteoblastic genes in osteosarcoma
por: Chen, Dafu, et al.
Publicado: (2023) -
Therapeutic Potential of Circular RNAs in Osteosarcoma
por: Wan, Ben, et al.
Publicado: (2020) -
Kinome-wide CRISPR-Cas9 knockout screens revealed PLK1 as a therapeutic target for osteosarcoma
por: Wang, Renxian, et al.
Publicado: (2023) -
Expression Patterns of Immune Genes Reveal Heterogeneous Subtypes of High-Risk Neuroblastoma
por: Liu, Zhenqiu, et al.
Publicado: (2020) -
Mechanical Stimulation on Mesenchymal Stem Cells and Surrounding Microenvironments in Bone Regeneration: Regulations and Applications
por: Sun, Yuyang, et al.
Publicado: (2022)